Showing results (111-120 of 365) with videos related to
Sort By:
Pageof 37
Journal of Breast Cancer|April 10, 2018
Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean EconomyJeong Hyun Park, Se Kyung Lee, Jeong Eon Lee, et al.Journal of Cancer Research and Clinical Oncology|June 17, 2010
The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patientsJong-Mu Sun, Young-Woong Won, Seung Tae Kim, et al.Cancers|October 14, 2023
Comprehensive Clinical Characterization of Decade-Long Survivors of Metastatic Breast CancerJunghoon Shin, Ji-Yeon Kim, Jung Min Oh, et al.Breast (Edinburgh, Scotland)|June 9, 2026
New perspectives on endocrine therapy suitability for hormone receptor-positive metastatic breast cancer in clinical practiceHope S Rugo, Giuseppe Curigliano, David W Cescon, et al.Springerplus|May 14, 2013
Clinical implication of Time To Brain Metastasis (TTBM) according to breast cancer subtypesHee Kyung Ahn, Yeon Hee Park, Su Jin Lee, et al.Nature Cancer|June 8, 2026
First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trialPeter Schmid, Seock-Ah Im, Zbigniew Nowecki, et al.Journal of Pathology and Translational Medicine|November 14, 2019
Clinicopathologic characteristics of HER2-positive pure mucinous carcinoma of the breastYunjeong Jang, Hera Jung, Han-Na Kim, et al.Nucleosides, Nucleotides & Nucleic Acids|December 11, 2007
Synthesis and antitumor activity of fluorocyclopentenyl-pyrimidinesLak Shin Jeong, Long Xuan Zhao, Won Jun Choi, et al.Journal of Breast Cancer|July 7, 2016
Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary NodesSang-Won Kim, Doo Ho Choi, Seung Jae Huh, et al.BMC Medicine|February 13, 2022
The impact of race and ethnicity in breast cancer-disparities and implications for precision oncologyKelly A Hirko, Gabrielle Rocque, Erica Reasor, et al.Pageof 37